Literature DB >> 11514497

Permanent pacing: new indications.

M R Gold1.   

Abstract

Mesh:

Year:  2001        PMID: 11514497      PMCID: PMC1729911          DOI: 10.1136/heart.86.3.355

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  29 in total

1.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.

Authors:  S J Connolly; C R Kerr; M Gent; R S Roberts; S Yusuf; A M Gillis; M H Sami; M Talajic; A S Tang; G J Klein; C Lau; D M Newman
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

2.  Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function.

Authors:  P F Bakker; H W Meijburg; J W de Vries; M M Mower; A C Thomas; M L Hull; E O Robles De Medina; J J Bredée
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

3.  Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting.

Authors:  T Levy; G Fotopoulos; S Walker; S Rex; M Octave; V Paul; M Amrani
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

4.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay.

Authors:  D A Kass; C H Chen; C Curry; M Talbot; R Berger; B Fetics; E Nevo
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

5.  Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).

Authors:  B J Maron; R A Nishimura; W J McKenna; H Rakowski; M E Josephson; R S Kieval
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

6.  Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation.

Authors:  Y Etienne; J Mansourati; M Gilard; V Valls-Bertault; J Boschat; D G Benditt; K G Lurie; J J Blanc
Journal:  Am J Cardiol       Date:  1999-04-01       Impact factor: 2.778

7.  Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

Authors:  M R Gold; R Brockman; R W Peters; M R Olsovsky; S R Shorofsky
Journal:  Am J Cardiol       Date:  2000-05-01       Impact factor: 2.778

8.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.

Authors:  R Sutton; M Brignole; C Menozzi; A Raviele; P Alboni; P Giani; A Moya
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

9.  Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators.

Authors:  A M Gillis; S J Connolly; P Lacombe; F Philippon; M Dubuc; C R Kerr; R Yee; M S Rose; D Newman; K M Kavanagh; M J Gardner; T Kus; D G Wyse
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

10.  Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing.

Authors:  F Victor; C Leclercq; P Mabo; D Pavin; A Deviller; C de Place; P Pezard; J Victor; C Daubert
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

View more
  1 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.